Phathom Pharmaceuticals Appoints Steven Basta as CEO to Accelerate Commercial Growth

Florham Park, NJ, April 1, 2025 (Globe Newswire) -- Steven Basta, a seasoned executive with over 25 years of industry leadership, has been appointed CEO of Phathom Pharmaceuticals. His prior roles include leading SaNOtize, Mahana Therapeutics, and BioForm Medical, where he oversaw successful product launches and business growth across pharma, digital therapeutics, and aesthetics. Phathom views his experience as pivotal to scaling VOQUEZNA® and driving the company’s next phase of commercial expansion.

Read full article here.